Product Information
LOSARTAN-HYDROCHLOROTHIAZIDE 100-12.5 MG TAB is a generic product labeled by Jubilant Cadista Pharmaceuticals Inc., priced at $0.0754 per EA under NDC 59746033810. Its NADAC has been published 271 times since Jan 27, 2021.
FDA first approved this application on Sep 18, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the losartan potassium and hydrochlorothiazide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
12.5; 100 mg/1; mg/1
Manufacturer
Jubilant Cadista Pharmaceuticals Inc.NDC
59746033810
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
3/18/2026
Active Ingredients
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUMApproval Type
Generic (ANDA)
FDA Application
ANDA201845FDA Approved
9/18/2012
TE Code
AB
On Market Since
10/30/2012
Pharmacological Classes
Price Statistics
The NADAC for LOSARTAN-HYDROCHLOROTHIAZIDE 100-12.5 MG TAB has been published 271 times since Jan 27, 2021, and over the history we have for it it has declined 57.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0754 per EA |
|---|---|
| All-time high | $0.2088 (Apr 13, 2022) |
| All-time low | $0.0746 (Nov 20, 2024) |
| 52-week high | $0.0973 |
| 52-week low | $0.0754 |
| Median price | $0.1243 |
| Average price | $0.1294 |
| Largest weekly change | -24.9% (Nov 20, 2024) |
| Weeks tracked | 271 |
| Tracking since | Jan 27, 2021 |
1W
N/A
1M
N/A
3M
N/A
6M
-3.0%
1Y
-22.6%
3Y
-40.1%
5Y
-52.8%
All
-57.3%
Last surveyed Apr 1, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LOSARTAN-HYDROCHLOROTHIAZIDE 100-12.5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for LOSARTAN-HYDROCHLOROTHIAZIDE 100-12.5 MG TAB, manufactured by Jubilant Cadista Pharmaceuticals Inc., is $0.0754 per EA (NDC 59746033810), effective Apr 1, 2026.
How has the price of LOSARTAN-HYDROCHLOROTHIAZIDE 100-12.5 MG TAB changed over time?
Over the history we have for it, the NADAC for LOSARTAN-HYDROCHLOROTHIAZIDE 100-12.5 MG TAB has declined 57.3%. It has been tracked across 271 weekly CMS publications since Jan 27, 2021.
What are the highest and lowest recorded NADAC prices for LOSARTAN-HYDROCHLOROTHIAZIDE 100-12.5 MG TAB?
Since Jan 27, 2021, the NADAC for LOSARTAN-HYDROCHLOROTHIAZIDE 100-12.5 MG TAB has ranged from a low of $0.0746 (Nov 20, 2024) to a high of $0.2088 (Apr 13, 2022), with a median of $0.1243 per EA.
Are there cheaper alternatives to LOSARTAN-HYDROCHLOROTHIAZIDE 100-12.5 MG TAB?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LOSARTAN-HYDROCHLOROTHIAZIDE 100-12.5 MG TAB, is $0.0750 per EA — about 1% below LOSARTAN-HYDROCHLOROTHIAZIDE 100-12.5 MG TAB.
Who manufactures LOSARTAN-HYDROCHLOROTHIAZIDE 100-12.5 MG TAB?
LOSARTAN-HYDROCHLOROTHIAZIDE 100-12.5 MG TAB (NDC 59746033810) is labeled by Jubilant Cadista Pharmaceuticals Inc., and CMS classifies it as a generic product.